New hope for IIH headache sufferers: migraine drug tested in landmark trial
Symptom relief
Not yet recruiting
This study tests whether eptinezumab, a drug used for migraines, can reduce the number of headache days in adults with idiopathic intracranial hypertension (IIH), a condition where high fluid pressure around the brain causes severe headaches. About 96 women aged 18-55 with chroni…
Phase: PHASE3 • Sponsor: Rigmor Højland Jensen • Aim: Symptom relief
Last updated Jun 27, 2026 13:07 UTC